215 related articles for article (PubMed ID: 30862685)
1. E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms.
Jolly MK; Ware KE; Xu S; Gilja S; Shetler S; Yang Y; Wang X; Austin RG; Runyambo D; Hish AJ; Bartholf DeWitt S; George JT; Kreulen RT; Boss MK; Lazarides AL; Kerr DL; Gerber DG; Sivaraj D; Armstrong AJ; Dewhirst MW; Eward WC; Levine H; Somarelli JA
Mol Cancer Res; 2019 Jun; 17(6):1391-1402. PubMed ID: 30862685
[TBL] [Abstract][Full Text] [Related]
2. Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis.
Pal M; Bhattacharya S; Kalyan G; Hazra S
Exp Cell Res; 2018 Jul; 368(2):137-146. PubMed ID: 29674112
[TBL] [Abstract][Full Text] [Related]
3. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
[TBL] [Abstract][Full Text] [Related]
4. A Ca
Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Bacigalupo ML; Manzi M; Espelt MV; Gentilini LD; Compagno D; Laderach DJ; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF
J Cell Physiol; 2015 Jun; 230(6):1298-309. PubMed ID: 25469885
[TBL] [Abstract][Full Text] [Related]
7. MiR-9 promotes synovial sarcoma cell migration and invasion by directly targeting CDH1.
Xu XZ; Li XA; Luo Y; Liu JF; Wu HW; Huang G
Int J Biochem Cell Biol; 2019 Jul; 112():61-71. PubMed ID: 30959202
[TBL] [Abstract][Full Text] [Related]
8. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.
Somarelli JA; Shetler S; Jolly MK; Wang X; Bartholf Dewitt S; Hish AJ; Gilja S; Eward WC; Ware KE; Levine H; Armstrong AJ; Garcia-Blanco MA
Mol Cell Biol; 2016 Oct; 36(19):2503-13. PubMed ID: 27402864
[TBL] [Abstract][Full Text] [Related]
11. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
[TBL] [Abstract][Full Text] [Related]
12. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
[TBL] [Abstract][Full Text] [Related]
13. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression.
Gulei D; Magdo L; Jurj A; Raduly L; Cojocneanu-Petric R; Moldovan A; Moldovan C; Florea A; Pasca S; Pop LA; Moisoiu V; Budisan L; Pop-Bica C; Ciocan C; Buiga R; Muresan MS; Stiufiuc R; Ionescu C; Berindan-Neagoe I
Cell Death Dis; 2018 Jan; 9(2):66. PubMed ID: 29352232
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
Abouhashem NS; Ibrahim DA; Mohamed AM
Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
16. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells.
Qi Y; Wang N; He Y; Zhang J; Zou H; Zhang W; Gu W; Huang Y; Lian X; Hu J; Zhao J; Cui X; Pang L; Li F
PLoS One; 2017; 12(8):e0182680. PubMed ID: 28829837
[TBL] [Abstract][Full Text] [Related]
18. RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.
Zinn R; Otterbein H; Lehnert H; Ungefroren H
Cells; 2019 Dec; 8(12):. PubMed ID: 31817229
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.
Chen A; Beetham H; Black MA; Priya R; Telford BJ; Guest J; Wiggins GA; Godwin TD; Yap AS; Guilford PJ
BMC Cancer; 2014 Jul; 14():552. PubMed ID: 25079037
[TBL] [Abstract][Full Text] [Related]
20. Detachment-induced E-cadherin expression promotes 3D tumor spheroid formation but inhibits tumor formation and metastasis of lung cancer cells.
Powan P; Luanpitpong S; He X; Rojanasakul Y; Chanvorachote P
Am J Physiol Cell Physiol; 2017 Nov; 313(5):C556-C566. PubMed ID: 28931539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
